SMOC
08 Jun 2021
Trial Summary
A surveillance study investigating whole body magnetic resonance imaging and other diagnostic procedures in people at high risk of cancer
Acronym:
SMOC+
ACTRN/NCT /ethics:
ACTRN12613000987763
Scientific title:
A surveillance study utilizing whole body magnetic resonance imaging and other surveillance procedures in people with germ line cancer gene mutations to investigate the prevalence and incidence of investigable lesions.
Sponsor / Cooperative group:
ASS/Garvan
Trial & Patient Characteristics
| Cancer Type | All cancers |
|---|---|
| Trial Type | Early detection, diagnosis, prognosis |
| Phase | - |
| Age Range | 18 years and older |
| Sex | All |
| Tumour Stream | - |
| Cancer Stage | - |
| Anticipated Start Date | 2013-06-09 |
| Anticipated End Date | 2026-09-01 |
Participating Hospitals
| Hospital | Royal Adelaide Hospital |
|---|---|
| Clinical Trial Coordinator | Anne Milton |
| anne.milton@sa.gov.au | |
| Phone | 08 7074 2342 |
| Principal Investigator | Professor Michael Brown |
| Recruitment Status | Recruiting |